Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NIOX Group
Oxford, England, United Kingdomniox.com ↗
- Ownership
- Public · NIOX
- Employees
- ~84
- Development stage
- Other
01
Overview
NIOX’s FeNO measurement devices are commercially available and widely used globally as a gold standard for non-invasive assessment of airway inflammation to aid asthma diagnosis and management. Over 50 million tests have been performed worldwide. The technology assists clinicians in diagnosing asthma, determining responsiveness to inhaled corticosteroids, tailoring steroid use, monitoring treatment compliance, and reducing exacerbation risk compared to traditional monitoring methods[1][2][8].
- Therapeutic areas
- Pulmonology
- Modalities
- Device (FeNO measurement device)Non-pharmacological therapy (diagnostic/monitoring tool)
- Industry
- Physiological Monitoring
02
Partnerships
AstraZeneca (historical COPD collaboration)ZEPHYRx (integration with cloud-based respiratory research platform)
03
Financials
- Market cap
- $342.5M
- Total revenue
- $65.2M
- Enterprise value
- $320.9M
Beyond the preview
Go deeper on NIOX Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NIOX Group.